NEW YORK (GenomeWeb) – BioMérieux said today that its third quarter revenues increased 16 percent on a reported basis year over year driven in part by a 60 percent spike in molecular biology sales.

For the three months ended Sept. 30, the Marcy L'Etoile, France-based in vitro diagnostics firm reported revenues of €478.3 million ($532.8 million) compared to €412 million in Q3 2014.

On an organic basis and at constant exchange rates, Q3 revenues grew 9 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.